Sâmara Pesqueira Souza

Sâmara Pesqueira Souza

Auto-generated profile, based on publicly available information

Sâmara Pesqueira Souza

Universidade Católica de Pernambuco

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
RMRayanne da Cunha Mendes
Rayanne da Cunha Mendes
SSSâmara Pesqueira Souza
Sâmara Pesqueira Souza
LJLuis Claudio Almeida da Silva Junior
Luis Claudio Almeida da Silva Junior
JCJordy Silva de Carvalho
Jordy Silva de Carvalho
VCVictor Hugo Oliveira Martins Coelho
Victor Hugo Oliveira Martins Coelho
WHWagner Gonçalves Horta
Wagner Gonçalves Horta
The present study aims to evaluate the effectiveness of pimavanserin in patients with psychosis in Parkinson's disease. Its effects on the clinical picture of psychosis were evaluated, as well as its adverse reactions and influences on patients' quality of life. This is a Systematic Literature Review of a qualitative nature, with a search strategy for the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Critical Appraisal Skill Program (CASP) methodological evaluation, analyzing a total of 8 articles. Articles were searched in PubMed databases, excluding simple literature reviews and incomplete articles. Those published in the last 10 years (2013-2023) and available in English were included. After a systematic analysis of the studies, it is concluded that pimavanserin demonstrates effectiveness in reducing hallucinogenic and delusional symptoms. Furthermore, it was found that the combination of pimavanserin with other medications, especially clozapine, showed promise in terms of safety, especially in improving cognitive functions. Patients showed improvements in the quality of sleep and wakefulness, in addition to a significant reduction in symptoms. Furthermore, side effects include pneumonia, episodes of syncope, obstructive pulmonary disease, pulmonary embolism and deep vein thrombosis. It is expected that future studies will continue to develop more intervention research on the effectiveness of the medication in treating Parkinson's disease, highlighting benefits and improvements in patients' quality of life through the use of the drug in medical practice.

1 July 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
MCMaria Isabel Gomes Campos
Maria Isabel Gomes Campos
BMBeatriz Clemente de Melo Moraes
Beatriz Clemente de Melo Moraes
MVMarisa Eduarda de Lima Vila
Marisa Eduarda de Lima Vila
HBHellen Karolliny da Silva Barros
Hellen Karolliny da Silva Barros
SSSâmara Pesqueira Souza
Sâmara Pesqueira Souza
MSManuela Barbosa Rodrigues de Souza
Manuela Barbosa Rodrigues de Souza
A perda progressiva de massa muscular caracteriza a Sarcopenia, sendo cada vez mais acentuada com a progressão da idade, propiciando inúmeros outros problemas de saúde desencadeados pelo quadro de sarcopenia. O presente estudo trata de uma revisão integrativa de literaturas que tenham por objetivo avaliar os benefícios do treinamento de força no estadiamento e regressão da sarcopenia em idosos, publicados entre o período de 2009 a 2021, disponibilizados em Português, Inglês. Foram selecionados artigos disponíveis na base de dados PubMed, e levado em conta pesquisa de abordagem para o estudo de testes controlados e aleatórios, meta-análises e ensaios clínicos. Para avaliar qualidade metodológica, utilizou-se o Critical Appraisal Skill Programme (CASP) adaptado, que abrangeu 10 itens a serem analisados. A sarcopenia apresenta prevalência mais frequente nas pessoas com mais de 60 anos tendo como um dos métodos de combate mais eficientes o treinamento de força. Além disso, envolve também melhoria de vida para os idosos acometidos por essa doença.

20 October 2023 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
RMRayanne da Cunha Mendes
Rayanne da Cunha Mendes
SSSâmara Pesqueira Souza
Sâmara Pesqueira Souza
LJLuis Claudio Almeida da Silva Junior
Luis Claudio Almeida da Silva Junior
JCJordy Silva de Carvalho
Jordy Silva de Carvalho
VCVictor Hugo Oliveira Martins Coelho
Victor Hugo Oliveira Martins Coelho
WHWagner Gonçalves Horta
Wagner Gonçalves Horta
The present study aims to evaluate the effectiveness of the ketogenic diet in improving the quality of life of patients with West Syndrome, in the control of spasms and convulsions, the benefits of its use alone and as an adjunct to conservative therapies, and its short-term consequences. and long term regarding its tolerance and side effects. This is a Systematic Literature Review of a qualitative nature, with a search strategy for the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Critical Appraisal Skill Program (CASP) methodological evaluation, analyzing a total of 6 articles. The articles were searched in the PubMed and SciELO databases, excluding simple literature reviews. Articles published in the last 10 years (2013-2023) and available in English were included. After a systematic analysis of the studies, it appears that the ketogenic diet is effective in reducing infantile spasms, especially in cases refractory to combined drug treatments. In addition, the side effects and relapses to the condition were lower than in patients who used adrenocorticotropic hormone. The Atkins diet approach has also been successful in stopping spasms. The ketogenic diet was well tolerated, with minimal side effects when combined with Vigabatrin. Side effects included increased triglycerides and ketone body. It is hoped that future studies will continue to highlight the benefits and improvements in the quality of life of patients with West Syndrome.